Wilson Sonsini Goodrich & Rosati represented Aurora Innovation, Inc. and Latham & Watkins represented the underwriters in the offering. Aurora Innovation, Inc. (Nasdaq: AUR) announced the...
Aurora’s $820 Million Common Stock Public Offering and Private Placement of Class A Common Stock
Welcome Homes’ $29 Million Series A Funding
Wilson Sonsini Goodrich & Rosati advised Welcome Homes on the deal. Welcome Homes, a New York City-based proptech company that delivers luxurious homes at a guaranteed...
Maven Clinic’s $90 Million Series E Financing
Wilson Sonsini advised Maven Clinic on the deal. Maven Clinic, one of the largest virtual clinics in women’s and family health, announced that it raised a...
KnowBe4’s $4.6 Billion Going-Private Transaction
Wilson Sonsini Goodrich & Rosati advised KnowBe4 and Potter Anderson & Corroon advised the Special Committee. Latham & Watkins represented Elephant Partners. Gibson, Dunn & Crutcher...
Redesign Health’s $65 Million Series C Financing
Wilson Sonsini Goodrich & Rosati advised Redesign Health on the deal. Redesign Health, a New York City-based company that builds other healthcare start-ups, closed a $65...
Equillium’s Acquisition of Metacrine
Wilson Sonsini advised Metacrine on the deal. Equillium, Inc. and Metacrine Inc. announced that the two companies have entered into a definitive merger agreement pursuant to...
Harmonic Discovery’s $8 Million Seed Funding
Wilson Sonsini Goodrich & Rosati advised Harmonic Discovery on the deal. Harmonic Discovery, a therapeutics company building an integrated computational and experimental platform for kinase drug...
Real’s $37 Million Series B Funding Round
Wilson Sonsini advised Real on the deal. Real, a mental health care company building a new platform-based therapy model, announced a $37 million Series B funding...
House Rx’s $30 Million Financing
Wilson Sonsini Goodrich & Rosati advised House Rx on the deal. House Rx, a health technology platform focused on improving affordability and patient access to specialty...
Verana Health’s $150 Million Series E Funding
Wilson Sonsini Goodrich & Rosati advised Verana Health on the deal. Verana Health, a digital health company that delivers quality drug lifecycle and medical practice insights...
Brex’s $300 Million Series D-2 Financing
Wilson Sonsini Goodrich & Rosati advised Brex on the deal. Brex, the U.S. fintech company reimagining finance for growing businesses, announced it has raised an additional...
Maven Clinic’s $110 Million Series D Funding
Wilson Sonsini Goodrich & Rosati and Jones Day advised Maven Clinic on the deal. Maven Clinic, the largest virtual clinic for women’s and family health, closed $110...